Hunting a T-cell cure for solid tumors, Rick Klausner’s Lyell steers to Nasdaq — with big dreams and fresh fortunes on the line

In the 3 years since ex-NCI chief Rick Klausner founded Lyell, he’s raised hundreds of millions of dollars, recruited some of the top scientists in …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Hunt­ing a T-cell cure for sol­id tu­mors, Rick Klaus­ner’s Lyell steers to Nas­daq — with big dreams and fresh for­tunes on the line